Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Health care logistics, PPE distribution and manufacturing

 Filing · LD-2 quarterly report Q3 termination
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Virginia
Representation ended
Sep 30, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 4
  • CHRISTOPHER E. WILCOX
    Previously held: LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
  • LAURA M SIMMONS
    Previously held: Advisor, Office of Legislative Affairs, Dept of Homeland Security
  • JEANNE HAGGERTY
    Previously held: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
  • ROBERT BUTORA
    Previously held: Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

FY 2027 Appropriations.

Specific issues "monitoring and reporting on reconciliation legislation"; implementation of PL 119-21.

Issues related to patient access to home medical equipment and related reimbursement.

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem